Inducible nitric oxide synthase in human diseases

Clinical and Experimental Immunology

Volumn 113, Issue 2, 1998, Pages 147-156

  Kroncke K D ^a,b   Fehsel, K ^a   Kolb Bachofen, V ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE SYNTHASE; TATA BINDING PROTEIN;

AUTOIMMUNITY; CELL ACTIVATION; CELL DIFFERENTIATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; INFECTION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SEQUENCE HOMOLOGY;

AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; DISEASE; ENZYME INDUCTION; HUMANS; INFLAMMATION; ISCHEMIA; NEOPLASMS; NEURODEGENERATIVE DISEASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0031949810     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00648.x     Document Type: Review

References (132)

1. Kröncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection. How, why, when where? NO Biol Chem 1997; 1:107-20.
2. Kröncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem 1995; 376:327-43.
3. Geller DA, Lowenstein CR, Shapiro RA et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acaci Sci USA 1993; 90:3491-5.
4. Charles IG, Palmer RM, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 1993; 90:11419-23.
5. Sherman PA, Laubach VE, Reep BR, Wood ER. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 1993; 32:11600-5.
6. Maier R, Bilbe G, Rediske J, Lotz M. Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta 1994; 1208:145-50.
7. Chartrain NA, Geller DA, Koty PP et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994; 269:6765-72.
8. Marsden PA, Heng HHG, Duff CL, Shi XM, Tsui LC, Hall AV. Localization of the human gene for inducible nitric oxide synthase (NOS2) to chromosome 17q11.2-q12. Genomics 1994; 19:183-5.
9. Xu W, Charles IG, Liu L, Moncada S, Emson P. Molecular cloning and structural organization of the inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun 1996; 219:784-8.
10. Hall AV, Antoniou H, Wang Y et al. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 1994; 269:33082-90.
11. Marsden PA, Heng HHQ, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268:17478-88.
12. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198:1027-33.
13. Xu W, Charles IG, Liu L, Koni PA, Moncada S, Emson P. Molecular genetic analysis of the duplication of human inducible nitric oxide synthase (NOS2) sequences. Biochem Biophys Res Commun 1995; 212:466-72.
14. Bloch KD, Wolfram JR, Brown DM et al. Three members of the nitric oxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17. Genomics 1995; 27:526-30.
15. Park CS, Lee HS, Lee HY, Krishna G. An unprocessed pseudogene of inducible nitric oxide synthase gene in human. NO Biol Chem 1997; 1:294-300.
16. Esumi H, Ogura T, Kurashima Y, Adachi H, Hokari A, Weisz A. Implication of nitric oxide synthase in carcinogenesis: analysis of the human inducible nitric oxide synthase gene. Pharmacogenetics 1995; 5:166-70.
17. Bellamy R, Hill AVS. Short report on DNA marker at candidate locus: a bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene. Clin Genet 1997; 52:192-3.
18. Kun FJ, Mordmüller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 1998; 351:265-6.
19. Zhang X, Laubach VE, Alley EW, Edwards KA, Sherman PA, Russell SW, Murphy WJ. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-γ. J Leukocyte Biol 1996; 59:575-85.
20. Spitsin SV, Farber JL, Bertovich M, Moehren G, Koprowski H, Michaels FH. Human- and mouse-inducible nitric oxide synthase promoters require activation of phosphatidylcholine-specific phospholipase C and NF-κB. Mol Med 1997; 3:315-26.
21. Kolyada AY, Savikovsky N, Madias NF. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue-specificity. Biochem Biophys Res Commun 1996; 220:600-5.
22. De Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, Billiar TR, Geller DA. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci USA 1996; 93:1054-9.
23. Linn SC, Morelli PJ, Edry I, Cottongim SE, Szabó C, Salzman AL. Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol 1997; 272:G1499-508.
24. Nunokawa Y, Ishida N, Tanaka S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun 1994; 200:802-7.
25. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1994; 12:5447-54.
26. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase pathway. J Exp Med 1995; 182:1683-93.
27. Yoshioka K, Thompson J, Miller MJS, Fisher JW. Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 1997; 232:702-6.
28. Chu SC, Wu HP, Banks TC, Eissa T, Moss J. Structural diversity in the 5′ untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem 1995; 270:10625-30.
29. Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. J Biol Chem 1996; 271:27184-7.
30. Zimmer A, Zimmer AM, Reynolds K. Tissue specific expression of the retinoic acid receptor-β2: regulation by short open reading frames in the 5′-noncoding region. J Cell Biol 1994; 127:1111-9.
31. Evans T, Carpenter A, Cohen J. Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process. Eur J Biochem 1994; 219:563-9.
32. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3′-translated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986; 83:1670-4.
33. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46:659-67.
34. Nunokawa Y, Oikawa S, Tanaka S. Expression of human inducible nitric oxide synthase is regulated by both promoter and 3′-regions. Biochem Biophys Res Commun 1997; 233:523-6.
35. Xie QW, Cho HJ, Calaycay J et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256:225-8.
36. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995; 59:533-47.
37. Denis M. Human monocytes/macrophages: NO or no NO? J Leukocyte Biol 1994; 55:682-4.
38. Schoendon G, Schneemann M, Walter R, Blau N, Hofer S, Schaffner A. Nitric oxide and infection: another view. Clin Infect Dis 1995; 21 (Suppl. 2):S152-7.
39. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukocyte Biol 1995; 58:643-9.
40. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274:1917-21.
41. Dighiero P, Reux I, Hauw JJ, Fillet AM, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neuroscience Letters 1994; 166:31-34.
42. Nagano I, Shapshak P, Yoshioka M, Xin K, Nakamura S,. Bradley WG. Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome. J Neurol Sci 1996; 136:117-28.
43. Stachura J, Konturek JW, Karczewska A, Domschkec W, Popiela T, Konturek SJ. Helicobacter pylori from duodenal ulcer patients expresses inducible nitric oxide synthase immunoreactivity in vivo and in vitro. J Physiol Pharmacol 1996; 47:131-5.
44. Mannick EE, Bravo LE, Zarama G et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996; 56:3238-43.
45. Nicholson S, Bonecini-Almeida MG, Lapa e Silva JR et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183:2293-302.
46. Furukawa K, Harrison DG, Saleh D, Shennib H, Chagnon FP, Giaid A. Expression of nitric oxide synthase in the human nasal mucosa. Am J Respir Crit Care Med 1996; 153:847-50.
47. Wheeler MA, Smith SD, Garcia-Cardeña G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997; 99:110-6.
48. Anstey NM, Weinberg JB, Hassanali MY et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 1996; 184:557-67.
49. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991; 49:380-7.
50. Muñoz-Fernández MA, Fernández MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and TFN-γ through a nitric oxide-dependent mechanism. Immunol Letters 1992; 33:35-40.
51. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossalayi MD. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92:7804-8.
52. Lee SC, Dickson DW, Brosnan CF, Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994; 180:365-9.
53. Evans TJ, Buttery LDK, Carpenter A, Springall DR, Cohen J. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 1996; 93:9553-8.
54. Benjamin N, O'Driscoll F, Dougall H, Duncan C, Smith L, Golden M, McKenzie H. Stomach NO synthesis. Nature 1994; 368:502.
55. Weller R, Pattullo S, Smith L, Golden M, Ormerod A, Benjamin N. Nitric oxide is generated on the skin surface by reduction of sweat nitrate. J Invest Dermatol 1996; 107:327-31.
56. Guo FH, de Raeve HR, Rice TW, Stuehr DJ, Thunnissen FBJM, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1996; 92:7809-13.
57. Lundberg JON, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Änggärd A, Lundberg JM, Alving K. High nitric oxide production in human paranasal sinuses. Nature Med 1995; 1:370-3.
58. Cobb JP, Danner RL. Nitric oxide and septic shock. JAMA 1996; 275:1192-6.
59. Thiemermann C. Nitric oxide and septic shock. Gen Pharmac 1997; 29:159-66.
60. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96:2357-63.
61. McInnes IB, Leung BP, Field M et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996; 184:1519-24.
62. Grabowski PS, Wright PK, van't Hof RJ, Helfrich MH, Oshima H, Ralston SH. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1997; 36:651-5.
63. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92:12041-5.
64. DeGroot CJA, Ruuls SR, Theeuwes JWM, Dukstra CD, van der Valk P. Immunocytohemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997; 56:10-20.
65. Konttinen YT, Platts LAM, Tuominen S et al. Role of nitric oxide in Sjögren's syndrome. Arthritis Rheum 1997; 40:875-83.
66. Hamid Q, Springall DR, Riveros-Moreno V et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342:1510-3.
67. Tracey WR, Xue C, Klinghofer V, Barlow J, Pollock JS, Förstermann U, Johns RA. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol 1994; 266:L722-7.
68. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Crit Care Med 1997; 155:1763-9.
69. Buttery LDK, Springall DR, Chester AH, Evans TJ, Stanfield N, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996; 75:77-85.
70. Lafond-Walker A, Chen CL, Augustine S, Wu TC, Hruban RH, Lowenstein CJ. Inducible nitrie oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. Am J Pathol 1997; 151:919-25.
71. Mourelle M, Casellas F, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR. Induction of nitric oxide synthase in colonic smooth muscle from palienls with toxic megacolon. Gastroenterology 1995; 109:1497-502.
72. Godkin AJ, de Belder AJ, Villa L, Wong A, Beesley JE, Kane SP, Martin JF. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26:867-72.
73. Singer II, Kawa DW, Scott S, Weidener RJ, Mumford RA, Riehl TE, Stenson WF. Expression of inducible nitric oxide synthase and nitrotyrosine in colonie epithelium in inflammatory bowel disease. Gastroentcrology 1996; 111:871-85.
74. Ikeda I, Kasajima T, Ishijamu S, Shimojo T, Takeo Y, Nishikawa S, Hiroe M, Mitsunaga A. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 1997; 92:1339-41.
75. Levine JJ, Pettei MJ, Valderrama E, Gold DM, Kessler BH, Trachtman H. Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J Pediatr Gastr Nutr 1998; 26:34-38.
76. Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32:275-82.
77. ter Steege J, Buurman W, Arends JW, Forget P. Presence of inducible nitric oxide synthase, nitrotyrosine. CD68, and CD14 in the small intestine in celiac disease. Lab Invest 1997; 77:29-36.
78. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int 1996; 50:392-9.
79. Haywood GA, Tsao PS, von der Leyen HE et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996; 93:1087-94.
80. Satoh M, Nakamura M, Tamura G, Makita S, Segawa I, Tashiro A, Satodate R, Hiramori K. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 1997; 29:716.
81. Adams V, Yu J, Möbius-Winkler S, Linke A, Weigl C, Hilbrich L, Schuler G, Hambrecht R. Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure. Biochem Mol Med 1997; 61:152-60.
82. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996; 347:1151-5.
83. Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996; 184:2007-12.
84. Kuhn A, Fehsel K, Lehmann P, Krutmann J, Ruzicka T, Kolb-Bachofen V. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 1998; 111:105-5.
85. Belmont HM, Levartovsky D, Goel A, Amin A, Giorno R, Rediske J, Skovron ML, Abramson SB. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40:1810-6.
86. Yamumoto T, Katayama I, Nishioka K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 1998; 25:314-7.
87. Rowe A, Farrell AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997; 136:18-23.
88. Takeichi O, Saito I, Hayashi M, Tsurumachi T, Saito T. Production of human-inducible nitric oxide synthase in radicular cysts. J Endodont 1998; 24:157-60.
89. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51:1219-22.
90. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996; 23:230-6.
91. Hooper DC, Bagasra O, Marini JC et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94:2528-33.
92. Kleemann R, Rothe H, Kolb-Bachofen V, Xie QW, Nathan C, Martin S, Kolb H. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Letters 1993; 328:9-12.
93. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994; 37:1154-8.
94. Kröncke KD, Kolb-Bachofen V, Bersehick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991; 175:752-8.
95. Steiner L, Kröncke KD, Fehsel K, Kolb-Bachofen V. Endothelial cells as cytotoxic effector cells: cytokine-activated islet endothelial cells lyse syngeneic islet cells via nitric oxide. Diabetologia 1997; 40:150-5.
96. Kröncke KD, Brenner H, Rodriguez ML, Etzkorn K, Noack EA, Kolb H, Kolb-Bachofen V. Pancreatic islet cells are highly susceptible towards the cytotoxic effects of chemically generated nitric oxide. Biochem Biophys Acta 1993; 1182:221-9.
97. Kröncke KD, Fehsel K, Sommer A, Rodriguez ML, Kolb-Bachofen V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotocin contributes to islet cell DNA damage. Biol Chem 1995; 376:179-85.
98. Eizirik DL, Delaney CA, Green MHL, Cunningham JM, Thorpe JR, Pipeleers DG, Hellerstöm C, Green IC. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol 1996; 118:71-83.
99. Eizirik DL, Sandler S, Welsh N et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93:1968-74.
100. Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 1993; 90:1731-5.
101. Vara E, Arias-Diaz J, Garcia C, Hernández J, Garcia-Carreras C, Cuadrado A, Balibrea JL. Production of TNFα, IL-1, 1L-6 and nitric oxide by isolated human islets. Transplant Proc 1995; 27:3367-71.
102. Vodovotz Y, Lucia MS, Flanders KC et al. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 1996; 184:1425-33.
103. Wallace MN, Geddes JG, Farquhar DA, Masson MR. Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques. Exp Neurol 1997; 144:266-72.
104. Hunot S, Boissière F, Faucheux B, Brugg B, Moualt-Prient A. Agid Y, Hirsch EC. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72:355-63.
105. Wildhirt SM, Dudek RR, Suzuki H, Narayan KS, Winder S, Choc J, Bing JR. Expression of nitric oxide synthase isoforms after myocardial infarctions in humans. Endothelium 1995; 3:209-24.
106. Cohhs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995; 55:727-30.
107. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RC, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72:41-44.
108. Dueñas-Gonzalez A, Isales CM, Abad-Hernandez MM, Gonzalez-Sarmiento R, Sangueza O. Rodriguez-Commes J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod Pathol 1997; 10:645-9.
109. Fujimoto H, Ando Y, Yamashita T et al. Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res 1997; 88:1190-8.
110. Ambs S, Merriam WG, Bennett WP et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998; 58:334-41.
111. Lewis NP, Tsao OPS, Rickenbacher PR et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996; 93:720-9.
112. McDermott CD, Gavita SM, Shennib H, Giaid A. Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis. Transplantation 1997; 64:270-4.
113. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, Al-Saffar N, Revell PA, Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 1997; 150:881-7.
114. Watkins SC, Macaulay W, Turner D, Kang R, Rubash HE, Evans CH. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am J Pathol 1997; 150:1199-206.
115. Hukkanen M, Corbett SA, Batten J et al. Aseptic loosening of total hip replacement. Macrophage expression of inducible nitric oxide synthase and cvclo-oxygenase-2 together with peroxynitrite formation, as a possible mechanism for early prosthesis failure. J Bone Joint Surg Br 1997; 79-B:467-74.
116. Yang CC, Alvarez RB, Engel WK, Askanas V. Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis. Neuroreport 1996; 8:153-8.
117. Wildhirt SM, Suzuki S, Wolf WP, Dudek R, Horstman D, Weismueller S, Reichart B. S-Methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem Biophys Res Commun 1996; 227: 328-33.
118. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997; 20:132-9.
119. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin JF. Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 1994; 152:5077-83.
120. Jenkins DC, Charles IG, Thomsen LL et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92:4392-6.
121. Suschek C, Schuy V, Bruch-Gerhartz D, Kroncke KD, Krutmann J, Kolb-Bachofen V. Nitric oxide protects endothelial cells from UVA-induced apoplosis. Immunobiol 1997; 197:297.
122. Tzeng E, Billiar RB. Nitric oxide and the surgical patient. Identifying therapeutic targets. Arch Surg 1997; 132:977-82.
123. Clark RSB, Kochanek PM, Schwarz MA, Schiding JK, Turner DS, Chen M, Carlos TM, Watkins SC. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr Res 1996; 39:784.
124. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL. Stimulation of the nitric oxide synthase pathway in human hepatocytes hy cytokines and endotoxin. J Exp Med 1992; 176:261-4.
125. Suschek C, Bruch D, Kröncke KD. Kolb-Bachofen V. Inducible nitric oxide synthase in human dermal endothelial cells. Eur J Clin Invest 1996; 26 (Suppl. 1):A4.
126. Takeichi O, Saito I, Okamoto Y, Tsurumachi T, Saito T. Production of human-inducible nitric oxide synthase in radicular cysts. J Endodont 1998; 24:157-60.
127. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 1994; 91:9253-6.
128. Bellmann K, Jäättelä M, Wissing D, Burkart V, Kolb H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Letters 1996; 391:185-8.
129. Bellmann K, Liu H, Burkart V, Pozzilli P, Cavollo MG, Jäättelä M, Steensgaard P, Kolb H. Immunobiol 1997; 197:230.
130. Berendji D, Kröncke KD, Kolb-Bachofen V. Reversible inactivation of the zinc finger transcription factor Sp 1 by nitric oxide suppresses IL-1β-mediated IL-2 gene expression in lymphocytes. Immunobiol 1997; 197:182-3.
131. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine proteasc protein (CPP)-32-like proteases. J Exp Med 1997; 185:601.
132. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nisticò G, Finazzi-Agrò A. S-nitrosylation regulates apoptosis. Nature 1997; 388:432.